Myriad Genetics (MYGN) to Evaluate MRD Testing With New Pact [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
the prognostic and predictive value of molecular residual disease (MRD) testing. Myriad Genetics' Precise MRD test will be used to investigate the widespread application of MRD testing across numerous cancer types. With its unique ability to monitor hundreds to thousands of tumor-specific variants, MYGN's Precise MRD test uses whole genome sequencing (WGS) to detect tumor-informed variants. This allows for remarkable sensitivity and quantification of circulating tumor DNA (ctDNA) in cancer patients' blood. More on Collaboration The SCRUM-MONSTAR-SCREEN-3 research will use Myriad Genetics' ultra-sensitive MRD test, Precise MRD, to track ctDNA over time in patients with a variety of solid tumor and hematological cancers. Image Source: Zacks Investment Research This project will explore how multi-omic profiling can be used to establish more tailored therapy and therapeutic methods across three study cohorts. Two of the three cohorts, which include about 1,200 patients from more
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024GlobeNewswire
- Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards [Yahoo! Finance]Yahoo! Finance
- The Former Director Of The NIH Shared His Prostate Cancer Journey. Use His Story To Reduce Your Risk Of Dying Of This Disease. [Forbes]Forbes
- Nearly Half of Americans Say They've Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor [Yahoo! Finance]Yahoo! Finance
- Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health MonitorGlobeNewswire
MYGN
Earnings
- 2/27/24 - Beat
MYGN
Sec Filings
- 5/1/24 - Form SC
- 4/25/24 - Form SC
- 4/17/24 - Form ARS
- MYGN's page on the SEC website